Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung-Jen Tang

Showing results (211-220 of 236) with videos related to

Pageof 24
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 12, 2024
Multicenter study on clinical outcomes and poor prognostic factors in patients with Klebsiella pneumoniae bacteremia receiving cefoperazone/sulbactam treatmentTsung-Ta Chiang, Ming-Hsien Chiang, Hung-Jen Tang, et al.
The Journal of Antimicrobial Chemotherapy|March 28, 2024
Trends of pre-treatment drug resistance in antiretroviral-naïve people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in TaiwanGuan-Jhou Chen, Chien-Yu Cheng, Chia-Jui Yang, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 21, 2018
Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter studyTe-Yu Lin, Chia-Jui Yang, Chung-Eng Liu, et al.
Plos One|March 17, 2018
Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in TaiwanChia-Wen Li, Chia-Jui Yang, Hsin-Yun Sun, et al.
International Journal of Antimicrobial Agents|July 21, 2021
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIVYu-Lin Lee, Kuan-Yin Lin, Shu-Hsing Cheng, et al.
International Journal of Antimicrobial Agents|July 4, 2012
Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010Han-Siong Toh, Yin-Ching Chuang, Chi-Chang Huang, et al.
International Journal of Antimicrobial Agents|July 4, 2012
Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010Yu-Lin Lee, Yao-Shen Chen, Han-Siong Toh, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 4, 2020
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected PatientsYu-Shan Huang, Chien-Yu Cheng, Bo-Huang Liou, et al.
Microbiology Spectrum|March 29, 2023
Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide among HIV/Hepatitis B Virus-Coinfected PatientsYu-Shan Huang, Chien-Yu Cheng, Hsin-Yun Sun, et al.
The Journal of Antimicrobial Chemotherapy|February 6, 2024
Efficacy of cefoperazone/sulbactam for ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and the factors associated with poor outcomesRou-Zhen Chen, Po-Liang Lu, Tsung-Ying Yang, et al.
Pageof 24

Showing results (211-220 of 236) with videos related to

Sort By:
Pageof 24
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 12, 2024
Multicenter study on clinical outcomes and poor prognostic factors in patients with Klebsiella pneumoniae bacteremia receiving cefoperazone/sulbactam treatmentTsung-Ta Chiang, Ming-Hsien Chiang, Hung-Jen Tang, et al.
The Journal of Antimicrobial Chemotherapy|March 28, 2024
Trends of pre-treatment drug resistance in antiretroviral-naïve people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in TaiwanGuan-Jhou Chen, Chien-Yu Cheng, Chia-Jui Yang, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 21, 2018
Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter studyTe-Yu Lin, Chia-Jui Yang, Chung-Eng Liu, et al.
Plos One|March 17, 2018
Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in TaiwanChia-Wen Li, Chia-Jui Yang, Hsin-Yun Sun, et al.
International Journal of Antimicrobial Agents|July 21, 2021
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIVYu-Lin Lee, Kuan-Yin Lin, Shu-Hsing Cheng, et al.
International Journal of Antimicrobial Agents|July 4, 2012
Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010Han-Siong Toh, Yin-Ching Chuang, Chi-Chang Huang, et al.
International Journal of Antimicrobial Agents|July 4, 2012
Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010Yu-Lin Lee, Yao-Shen Chen, Han-Siong Toh, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 4, 2020
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected PatientsYu-Shan Huang, Chien-Yu Cheng, Bo-Huang Liou, et al.
Microbiology Spectrum|March 29, 2023
Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide among HIV/Hepatitis B Virus-Coinfected PatientsYu-Shan Huang, Chien-Yu Cheng, Hsin-Yun Sun, et al.
The Journal of Antimicrobial Chemotherapy|February 6, 2024
Efficacy of cefoperazone/sulbactam for ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and the factors associated with poor outcomesRou-Zhen Chen, Po-Liang Lu, Tsung-Ying Yang, et al.
Pageof 24